Brief: Progressive Care Sees 620% Annual Growth In COVID-19 Testing To $4.3 Mln Revenue
01/02/2022 12:03
Feb 1 (Reuters) - Progressive Care Inc RXMD.PK :
* PROGRESSIVE CARE SEES 620% ANNUAL GROWTH IN COVID-19
TESTING TO
$4.3 MILLION REVENUE
Source text for Eikon: ID:nGNX93NlhB
Further company coverage: RXMD.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Progressive Care
See all newsBrief: Global Telesat Begins Sales of SpaceX's Starlink as Authorized Reseller Through Joint Venture Agreement with Pivotel Solutions Inc. (dba Pulsar)
Brief: NextPlat Announces Proposed Business Combination With Progressive Care
Nextplat soars on merger with Progressive Care
Brief: NextPlat Receives Initial Approvals To Launch OPKO Health on Alibaba's Tmall Global Platform in China
Brief: Progressive Care's Pharmcorx Pharmacies Expands Medicare Advantage With Prohealth Connect